Model-Based Meta-Analysis to Optimize Staphylococcus aureus‒Targeted Therapies for Atopic Dermatitis.

Area of Science:

• Dermatology
• Microbiology
• Computational Biology

Background:

• Clinical trials of Staphylococcus aureus (S. aureus)-targeted therapies for atopic dermatitis (AD) yield conflicting results.
• Understanding the complex interplay between S. aureus, coagulase-negative Staphylococcus (CoNS), and AD pathogenesis is crucial.

Purpose of the Study:

• To investigate the causes of conflicting results in S. aureus-targeted AD therapies using a model-based meta-analysis.
• To propose strategies for enhancing the efficacy of S. aureus-targeted treatments for AD.

Main Methods:

• Development of a mathematical model simulating systems-level AD pathogenesis.
• Incorporation of dynamic interactions between S. aureus and CoNS within the model.
• Model simulations to evaluate the impact of S. aureus eradication and CoNS presence on AD severity.

Main Results:

• Model simulations replicated detrimental effects of certain treatments targeting S. aureus and CoNS.
• Removing bactericidal activity against CoNS abolished observed negative impacts on AD severity.
• S. aureus eradication alone, without affecting CoNS, achieved Eczema Area and Severity Index 75 comparable to dupilumab.
• Combination therapy (S. aureus eradication + dupilumab) showed superior efficacy, particularly for dupilumab poor responders.

Conclusions:

• Killing CoNS exacerbates AD severity, highlighting the importance of selective S. aureus targeting.
• S. aureus-specific eradication, preserving CoNS, offers a promising therapeutic strategy for AD patients.
• This approach may benefit individuals with AD who do not respond well to existing treatments like dupilumab.